ARS Pharmaceuticals share price logo

ARS Pharmaceuticals

NASDAQ: SPRY

Small Cap

$4.15

-0.01

(-0.36%)

Live

as on

ARS Pharmaceuticals Stock Performance

as on September 18, 2026 at 1:13 am IST

  • Day's Low

    Day's High

    $4.13
    $4.29
    downward going graph

    0.48%

    Downside

    3.37%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.13
    $13.15
    downward going graph

    0.60%

    Downside

    216.87%

    Upside

    downward going graph

ARS Pharmaceuticals share price movements today

Previous Close
$4.17
Open
$4.28
Volume
256.6K
Market Cap
$422.7M
Day's Low - High
$4.13 - $4.29
52 Week Low - High
$4.13 - $13.15

ARS Pharmaceuticals Historical Returns

1 Month Return
-33.25 %
3 Month Return
-57.93 %
1 Year Return
-56.48 %
3 Year Return
-42.63 %
5 Year Return
0 %

ARS Pharmaceuticals Stock Fundamentals & Key Indicators

Check ARS Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$422.7M

EPS (TTM)

-1.87

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-214.6M

Revenue (TTM)

116.9M

Profit Margin

-184.24%

Return On Equity TTM

-210.35%

ARS Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ARS Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ARS Pharmaceuticals image
ARS Pharmaceuticals
BUY$422.7MNANA-184.24%0.00%
Revolution Medicines image
Revolution Medicines
BUY$43.9B527.35%NA0.00%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.4B172.58%29.7186.04%0.00%
Moderna image
Moderna
BUY$57.4B-66.14%-18.02-12.57%0.00%
Regeneron image
Regeneron
BUY$81.7B18.83%18.4884.86%0.48%

Stock Returns calculator for ARS Pharmaceuticals Stock including INR - Dollar returns

The ARS Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ARS Pharmaceuticals investment value today

Current value as on today

₹47,410

Returns

-₹52,590

(-52.59%)

Returns from ARS Pharmaceuticals Stock

-₹56,635 (-56.64%)

Dollar Impact

₹4,045 (+4.05%)

Analyst Recommendation on ARS Pharmaceuticals Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for ARS Pharmaceuticals. Average target price of $22.5

ARS Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on ARS Pharmaceuticals.

What analysts predicted

81.56%UPSIDE

Target Price

$22.5

Current Price

$4.15

Analyzed by

3 Analysts

Target

$22.50

ARS Pharmaceuticals target price $22.5, a slight upside of 81.56% compared to current price of $4.15. According to 3 analysts rating.

Indian Investors' Interest in ARS Pharmaceuticals Stock

Search interest for ARS Pharmaceuticals Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

ARS Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
2
86
7
15
32
28
22
33
Gross Profit
-5
-6
1
82
3
10
24
24
16
20
Operating Income
-13
-15
-21
47
-37
-47
-53
-41
-60
-61
EBITDA
-10
-12
-19
50
-33
-44
-48
-40
-57
-59
Interest Expense
-
-
-
-
-
-
-
2
2
2
Depreciation
-1
-1
-1
-1
-1
-1
0
0
0
0
Income Before Tax
-10
-12
-19
50
-33
-44
-51
-41
-60
-62
Income Tax Expense
0
-
-
0
-
-
-
0
-
-
Net Income
-10
-12
-19
49
-33
-44
-51
-41
-60
-62
Net Profit Margin
0.00%
-2503.20%
-924.95%
57.67%
-425.69%
-285.57%
-157.38%
-147.13%
-267.26%
-185.21%

ARS Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
17
5
1
0
89
84
Gross Profit
3
5
-15
0
68
63
Operating Income
0
-19
-35
-67
-3
-179
EBITDA
0
-19
-34
-54
8
-167
Interest Expense
0
0
0
-
-
2
Depreciation
0
0
0
0
-7
-4
Income Before Tax
-1
-20
-34
-54
8
-171
Income Tax Expense
0
0
0
0
0
0
Net Income
-1
-20
-34
-54
7
-171
Net Profit Margin
-5.97%
-367.65%
-2635.41%
-181216.67%
8.97%
-203.25%

ARS Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-19
49
-33
-44
-51
-41
-60
-62
Operating Cash Flow
-7
-14
42
-40
-39
-47
-43
-44
-60
Investing Cash Flow
-12
16
-101
29
48
-44
24
27
41
Financing Cash Flow
0
0
70
0
2
100
1
0
3
Change in Cash
-19
3
11
-10
11
8
-18
-16
-16

ARS Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-1
-20
-34
-54
7
-171
Operating Cash Flow
-18
9
-17
-40
-59
13
-170
Investing Cash Flow
0
0
0
0
-87
-106
56
Financing Cash Flow
8
5
53
190
6
72
104
Change in Cash
-10
14
35
150
-139
-20
-9

Mutual Funds that own ARS Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in ARS Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.497884%
2484080
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)
1.08058%
1074609
Fidelity Concord Street Trust
0.679169%
675416
Fidelity Salem Street Trust
0.642187%
638638
VANGUARD SCOTTSDALE FUNDS
0.353279%
351327
See all

Global Institutional Holdings in ARS Pharmaceuticals

Funds
Holdings
Peter Kolchinsky
10.92%
James E. Flynn
7.55%
Vanguard
3.08%
iShares
3.08%
SPDR
2.6%
See all

ARS Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 20 August

    Fri, 01:56 AM

    -

    ARS Pharmaceuticals holder plans to sell 25,000 shares after recent sales of 100,000 shares.

Insights on ARS Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.68M → 33.65M (in $), with an average increase of 32.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 482.5% return, outperforming this stock by 539.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.1% return, outperforming this stock by 69.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SPRY stock has moved down by -17.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -41.32M → -62.33M (in $), with an average decrease of 24.8% per quarter

About ARS Pharmaceuticals

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
OrganisationARS Pharmaceuticals
Headquarters11682 El Camino Real, San Diego, CA, United States, 92130
IndustryBiotechnology
CEOMr. Donn Casale
E-voting on sharesClick here to vote

Key Management of ARS Pharmaceuticals

Name

Title

Mr. Justin Chakma

Chief Business Officer

Mr. Donn Casale

CEO, President & Director

Ms. Kathleen D. Scott CPA

Chief Financial Officer

Mr. Brian T. Dorsey M.S.

Chief Operating Officer

Mr. Daniel Relovsky

Senior Vice President of Marketing

Dr. Robert Bell Ph.D.

Co-Founder & Chief Science Officer

Mr. Alexander A. Fitzpatrick Esq.

Chief Legal Officer & Secretary

Ms. Lynda Harris

Vice President of Human Resources

Mr. Eric Karas

Chief Commercial Officer

FAQs

What is ARS Pharmaceuticals share price today?

ARS Pharmaceuticals share price today is $4.15 as on . ARS Pharmaceuticals share today touched a day high of $4.29 and a low of $4.13.

What is the 52 week high and 52 week low for ARS Pharmaceuticals share?

ARS Pharmaceuticals share touched a 52 week high of $13.15 on and a 52 week low of $4.13 on . ARS Pharmaceuticals stock price today i.e. is trending at $4.15,which is 68.44% down from its 52 week high and 0.61% up from its 52 week low.

What is ARS Pharmaceuticals's market capitalisation today?

ARS Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in ARS Pharmaceuticals Stock (SPRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ARS Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ARS Pharmaceuticals Shares that will get you 0.3614 shares as per ARS Pharmaceuticals share price of $4.15 per share as on September 17, 2026 at 7:43 pm IST.

What is the minimum amount required to buy ARS Pharmaceuticals Stock (SPRY) from India?

Indian investors can start investing in ARS Pharmaceuticals (SPRY) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in ARS Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on ARS Pharmaceuticals share’s latest price of $4.15 as on September 17, 2026 at 7:43 pm IST, you will get 2.4096 shares of ARS Pharmaceuticals. Learn more about fractional shares .